Zobrazeno 1 - 10
of 174
pro vyhledávání: '"Hövels, A M"'
Autor:
ten Ham, Renske M.T., van Nuland, Merel, Vreman, Rick A., de Graaf, Laurens G., Rosing, Hilde, Bergman, André M., Huitema, Alwin D.R., Beijnen, Jos H., Hövels, Anke M.
Publikováno v:
In Value in Health January 2021 24(1):121-128
Autor:
Vreman, Rick A., Mantel-Teeuwisse, Aukje K., Hövels, Anke M., Leufkens, Hubert G.M., Goettsch, Wim G.
Publikováno v:
In Value in Health January 2020 23(1):10-16
Publikováno v:
The European Journal of Health Economics, 2019 Aug 01. 20(6), 857-867.
Externí odkaz:
https://www.jstor.org/stable/45157025
Publikováno v:
In Research in Social and Administrative Pharmacy September 2019 15(9):1088-1094
Autor:
van de Pol, Jeroen M., Geljon, Jurjen G., Belitser, Svetlana V., Frederix, Geert W.J., Hövels, Anke M., Bouvy, Marcel L.
Publikováno v:
In Research in Social and Administrative Pharmacy January 2019 15(1):70-76
Autor:
Frederix, Gerardus W.J., Severens, Johan L., Hövels, Anke M., Raaijmakers, Jan A.M., Schellens, Jan H.M.
Publikováno v:
In Value in Health September-October 2013 16(6):1100-1102
Autor:
Frederix, Gerardus W.J., Quadri, Nuz, Hövels, Anke M., van de Wetering, Fleur T., Tamminga, Hans, Schellens, Jan H.M., Lloyd, Andrew J.
Publikováno v:
In Clinical Therapeutics April 2013 35(4):e1-e7
Autor:
Frederix, Gerardus W.J., Severens, Johan L., Hövels, Anke M., Raaijmakers, Jan A.M., Schellens, Jan H.M.
Publikováno v:
In Value in Health January-February 2012 15(1):94-105
Autor:
Geenen, Joost W., Belitser, Svetlana V., Vreman, Rick A., van Bloois, Martijn, Klungel, Olaf H., Boersma, Cornelis, Hövels, Anke M., Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
The European Journal of Health Economics
European Journal of Health Economics, 21(6), 845-853. Springer Verlag
European Journal of Health Economics, 21(6), 845. Springer Verlag
European Journal of Health Economics, 21(6), 845-853. Springer Verlag
European Journal of Health Economics, 21(6), 845. Springer Verlag
Background High budget impact (BI) estimates of new drugs have led to decision-making challenges potentially resulting in restrictions in patient access. However, current BI predictions are rather inaccurate and short term. We therefore developed a n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7e724ef5c1f915bcbda1ff9b9804159
http://europepmc.org/articles/PMC7366590
http://europepmc.org/articles/PMC7366590
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.